Long-term outcome of patients managed with sentinel lymph node biopsy alone for node-negative invasive breast cancer

Archives of Surgery

Volumn 147, Issue 11, 2012, Pages 1047-1052

  Kapoor, Nimmi S ^a,b   Sim, Myung Shin ^a   Lin, Jennifer ^a   Giuliano, Armando E ^c  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c Samuel Oschin Comprehensive Cancer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER SURVIVAL; DEATH; DISEASE FREE SURVIVAL; EARLY CANCER; FOLLOW UP; HUMAN; LONG TERM CARE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 84869386749     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2012.1563     Document Type: Article

References (19)

1. Fisher B, Bauer M, Wickerham DL, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update. Cancer. 1983;52(9):1551-1557. (Pubitemid 13018271)
2. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically nodenegative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927-933.
3. Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. 2010;251(4):595-600.
4. Fougo JL, Dinis-Ribeiro M, Araújo C, et al. Impact of lymphadenectomy on axillary recurrence and morbidity of the upper limb in breast cancer patients with negative sentinel node: a prospective randomised study [in Spanish]. Cir Esp. 2011;89(5):307-316.
5. Fleissig A, Fallowfield LJ, Langridge CI, et al. Post-operative arm morbidity and quality of life: results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat. 2006;95(3):279-293.
6. Lucci A, McCall LM, Beitsch PD, et al American College of Surgeons Oncology Group. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25(24):3657-3663. (Pubitemid 47372604)
7. Ashikaga T, Krag DN, Land SR, et al National Surgical Adjuvant Breast, Bowel Project. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection vs axillary dissection. J Surg Oncol. 2010;102(2):111-118.
8. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222(3):394-401.
9. Cote RJ, Peterson HF, Chaiwun B, et al International Breast Cancer Study Group. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet. 1999;354(9182):896-900. (Pubitemid 29424019)
10. van der Heiden-van der Loo M, Bezemer PD, Hennipman A, et al. Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol. 2006;32(7):710-714.
11. Hansen NM, Grube B, Ye X, et al. Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol. 2009;27(28):4679-4684.
12. Giuliano AE, Hawes D, Ballman KV, et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with earlystage invasive breast cancer. JAMA. 2011;306(4):385-393.
13. Weaver DL, Ashikaga T, Krag DN, et al. Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med. 2011;364(5):412-421.
14. Takeshita T, Tsuda H, Moriya T, et al. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up. Ann Surg Oncol. 2012;19(4):1160-1166.
15. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391-401. (Pubitemid 24313232)
16. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg. 1997;226(3):271-278. (Pubitemid 28070919)
17. Edge SE. Breast cancer. In: Edge SE, Byrd DR, Compton C, et al, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009.
18. Darby S, McGale P, Correa C, et al Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011;378(9804):1707-1716.
19. Wernicke AG, Goodman RL, Turner BC, et al. A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance. Breast Cancer Res Treat. 2011;125(3):893-902.